- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Daratumumab
Total 321 results
-
AbbVieJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, Denmark, France, Germany, Japan
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
Karyopharm Therapeutics IncCompletedMultiple MyelomaUnited States, Belgium, Austria, France, Germany, Greece
-
Janssen Research & Development, LLCCompletedMyelodysplastic SyndromesUnited States, Belgium, Italy, Spain, Netherlands, Russian Federation
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, France, Spain, Czechia
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Belgium, France, Germany, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Abdullah KhanTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Attaya SuvannasankhaJanssen Scientific Affairs, LLC; Indiana Institute for Medical ResearchWithdrawnMultiple MyelomaUnited States
-
Janssen Research & Development, LLCCompleted
-
Dana-Farber Cancer InstituteJanssen, LPCompletedWaldenström MacroglobulinemiaUnited States
-
European Myeloma NetworkJanssen, LPActive, not recruitingMultiple Myeloma | Extramedullary PlasmacytomaTurkey, Italy, Greece
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
PETHEMA FoundationActive, not recruitingNewly Diagnosed Multiple MyelomaSpain
-
Fernando FervenzaCompleted
-
Johnson & Johnson Private LimitedCompleted
-
Fondazione Italiana Linfomi ONLUSActive, not recruitingRelapsed T-Cell Lymphoma | Refractory T-Cell LymphomaItaly
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNetherlands, Belgium, Germany, Spain, Czechia, Greece, Italy, Denmark, Serbia, Turkey
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
Wake Forest University Health SciencesJanssen Research & Development, LLCWithdrawnMultiple MyelomaUnited States
-
Sumithira VasuCompletedRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Recurrent Adult Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
Corvus Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
Tel-Aviv Sourasky Medical CenterCompletedPlasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Myeloma, Plasma-CellIsrael
-
Washington University School of MedicineJanssen, LPWithdrawn
-
University of TetovaUniversity of Tetova, Faculty of Medical SciencesCompletedInfertility | Male | OligoasthenozoospermiaNorth Macedonia
-
Janssen Scientific Affairs, LLCCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbJanssen Biotech, Inc.CompletedAdvanced CancerUnited States, Switzerland, France, Puerto Rico, Italy, Germany, Australia, Canada, Spain
-
University Hospital, LimogesCompletedAmyloidosisFrance, Italy
-
Grupo Cooperativo de Hemopatías MalignasWithdrawn
-
Boston Medical CenterJanssen PharmaceuticalsCompleted
-
Nantes University HospitalActive, not recruiting
-
Hoffmann-La RocheCompleted
-
University Hospital, LilleJanssen, LP; Intergroupe Francophone du MyelomeCompletedMultiple MyelomaFrance, Belgium
-
Janssen Research & Development, LLCCompletedLymphomaTaiwan, China, Singapore, Korea, Republic of, Hong Kong
-
Intergroupe Francophone du MyelomeJanssen Research & Development, LLC; HOVON - Dutch Haemato-Oncology AssociationActive, not recruitingMultiple MyelomaNetherlands, France, Belgium
-
Janssen Research & Development, LLCCompleted
-
National Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
Ronald WittelesWithdrawnHeart Transplant Failure and Rejection | Allosensitization
-
Janssen Research & Development, LLCApproved for marketing
-
Janssen Pharmaceutical K.K.Completed
-
Assistance Publique - Hôpitaux de ParisWithdrawn
-
Hoffmann-La RocheCompletedMultiple MyelomaUnited States, Australia, United Kingdom
-
Janssen Research & Development, LLCGenentech, Inc.CompletedCarcinoma, Non-Small-Cell LungFrance, United States, Spain, Hungary, Poland
-
Ohio State University Comprehensive Cancer CenterCompleted